Tirzepatide × Elutide - Lab Test, February 2026
Janoshik Labs publishes a public verification portal. Any test attributed to this lab can be looked up and confirmed directly with the lab — so this result doesn't rest on our review alone.
Test results
About this test
This independent test report from Janoshik Labs confirms Tirzepatide 60mg from Elutide at 99.81% purity with 72.19mg tested content. The analysis was conducted on February 9, 2026.
Tirzepatide is a dual GIP/GLP-1 receptor agonist researched for its potential in weight management, metabolic regulation, and glycemic control through enhanced appetite suppression and improved insulin sensitivity. A purity level of 99.81% indicates minimal impurities and high-grade synthesis.
The full certificate of analysis is available for download on this page.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion
No comments yet. Sign in to be the first to discuss this test.